Health Condition 1: L80- Vitiligo
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1.Hypo pigmented patches with hyper pigmented border without any structural changes in any part of the body except lips, fingers and genital area. 2.Patient’s informant / Parent and patient are willing to sign the informed consent form and assent form stating that he/she will consciously stick to the treatment during 48 days but can opt out of the trial of his / her own conscious discretion. 3.Willing to cooperate for taking photographs whenever required with his/her consent.
Exclusion criteria
Exclusion criteria: 1.Albinism 2.Leprosy 3.Tinea versicolor 4.Burn scar 5.Pityriasis alba
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Efficacy of the trial drug measured by Vitiligo Area Scoring Index (VASI) ScoreTimepoint: SCREENING - 3 MONTHS PATIENT ENROLLMENT - 5 MONTHS TRIAL DRUG - 6 MONTHS DATA ANALYSIS - 1 MONTHS FOLLOW UP - 3 MONTHS | — |
Secondary
| Measure | Time frame |
|---|---|
| Pharmacological activity of the trial drug-anti oxidant and thyrosinase activity will be analysed.Timepoint: Preparation of trial drug-3 months Screening the drug activity-3 months | — |
Countries
India
Contacts
National Institute of Siddha